Public Release: 

Whole genome sequencing better at tracing TB outbreaks than standard test

Press Release from PLOS Medicine


A new form of genetic testing of the bacteria that causes tuberculosis can provide better information on TB transmission and also trace TB outbreaks more accurately than the current standard test, according to a study from Germany published in this week's PLOS Medicine.

A team of researchers led by Stefan Niemann from Forschungszentrum Borstel, Molecular Mycobacteriology, compared the results of the two types of tests on 86 M. tuberculosis isolates from a TB outbreak in the German states of Hamburg and Schleswig-Holstein between 1997 and 2010, in which 2301 people were diseased in the study period.

They found that the new test (whole genome sequencing) provided more accurate information on clustering and longitudinal spread of the pathogen than the standard test (classical genotyping). Importantly, whole genome sequencing revealed that first outbreak isolates were falsely clustered by classical genotyping and do not belong to one recent transmission chain.

By using whole genome sequencing, the authors estimated that the genetic material of M. tuberculosis evolved at a rate at 0.4 mutations per genome per year, suggesting that the bacterium grows in its natural host (infected people) with a doubling time of 22 hours, or 400 generations per year. This finding about the evolution of M. tuberculosis indicates how information from whole genome sequencing can be used to help trace future outbreaks.

Importantly, as the costs of whole genome sequencing are declining, this test could soon become the standard method for identifying transmission patterns and rates of infectious disease outbreaks.

The authors say: "Our study demonstrates that whole genome sequencing-based typing provides epidemiologically relevant resolution of large, longitudinal [Mycobacterium tuberculosis] outbreaks much more efficiently than classical genotyping."

They continue: "We envision that [whole genome sequencing] progressive effective implementation will be accelerated by the continuously decreasing sequencing costs, broader distribution of so-called bench top genome sequencers, and upcoming bioinformatics developments to facilitate quick and relevant interpretation of the resulting data in public health and medical contexts."


Funding: This work was supported by the Schleswig-Holsteinische Gesellschaft zur Verhutung und Bekampfung der Tuberkulose und der Lungenkrankheiten e.V., the EU FP7 TB-PAN-NET (FP7-223681), EU FP7 Patho-Ngen-Trace (FP7- 278864-2), ATM Museum National d'Histoire Naturelle ''Biodiversite et role des microorganismes dans les ecosystemes actuels et passes'' and the BMBF funded TBornotTB network (01KI0784) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: PS is a consultant for Genoscreen. All other authors have declared that no competing interests exist.

Citation: Roetzer A, Diel R, Kohl TA, Ruckert C, Nubel U, et al. (2013) Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological Study. PLoS Med 10(2): e1001387. doi:10.1371/journal.pmed.1001387



PD Dr. Stefan Niemann
Molecular Mycobacteriology, Forschungszentrum Borstel
Borstel, Germany

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.